[1] 刘明波,何新叶,杨晓红,等.《中国心血管健康与疾病报告2023》要点解读[J].中国心血管杂志,2024,29(4):305-324.
[2] Alkhawam H, Zaiem F, Sogomonian R, et al.Coronary Artery Disease in Young Adults. Am [J] Med Sci. 2015;350(6):479-483.
[3] Cetin MS, Ozcan Cetin EH, Kalender E, et al.Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. Heart Lung Circ. 2016;25(11):1077-1086.
[4] Tousoulis D, Charakida M, Stefanadis C.Endothelial function and inflammation in coronary artery disease. Postgrad Med J. 2008;84(993):368-371.
[5] Westerterp M, Gourion-Arsiquaud S, Murphy AJ, et al.Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012;11:195-206.
[6] Wang N, Lan D, Chen W, et al.ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004;101:9774-9.
[7] Collot-Teixeira S, Martin J, McDermott-Roe C, et al. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007;75:468-77.
[8] Badimon L, Storey RE, Vilahur G. Update on lipids, inflammation and atherothrombosis.Thromb Haemost2011;105 Suppl 1:S34-42.
[9] 刘红利,孙颖,郎艳松,等.单核/巨噬细胞脂质代谢和炎症在动脉粥样硬化中的作用[J].细胞与分子免疫学杂志,2014,30(11):1224-1227.
[10] Ghattas A, Griffiths HR, Devitt A, et al.Monocytes in coronary artery disease and atherosclerosis: where are we now?. [J] Am Coll Cardiol. 2013;62(17):1541-1551.
[11] 赵凯,陈文强,徐兴晟,等.单核细胞自体吞噬相关基因蛋白表达与冠状动脉粥样硬化斑块易损性的关系[J].中国动脉硬化杂志,2014,22(1):37-42.
[12] 刘森,王丹,万进东,等.稳定性冠心病患者外周血单核细胞亚型分布特征及影响因素[J].实用医学杂志,2018,34(23):3908-3912.
[13] 许成. 单核细胞亚群、单核细胞/高密度脂蛋白胆固醇比值与STEMI患者早期预后的相关性研究[D].南方医科大学,2021.
[14] Maekawa Y, Anzai T, Yoshikawa T, et al.Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. [J] Am Coll Cardiol. 2002;39(2):241-246.
[15] Shantsila E, Tapp LD, Wrigley BJ, et al.Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. Atherosclerosis. 2014;234(1):4-10.
[16] 高翔,宋诗飞,李娜,等.MHR和LDL-C/HDL-C比值与ACS患者冠状动脉病变严重程度的关系[J].江苏医药,2023,49(5):510-514.
[17] Havel RJ.High-density lipoproteins, cholesterol transport and coronary heart disease. Circulation. 1979;60(1):1-3.
[18] Natarajan P, Ray KK, Cannon CP.High-density lipoprotein and coronary heart disease: current and future therapies.J Am Coll Cardiol.2010 Mar 30;55(13):1283-99.
[19] Papageorgiou N, Zacharia E, Androulakis E, et al.HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation. Expert Opin Ther Targets. 2016;20(8):907-921.
[20] Wang P, Guo X, Zhou Y, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol (Lausanne). 2022;13:944991. Published 2022 Sep 9.
[21] 福尔凯提·阿卜力米提,黄定.单核细胞/高密度脂蛋白胆固醇比值、红细胞分布宽度、平均血小板体积与早发冠心病的相关性研究[J].医学信息,2023,36(18):99-104.
[22] Kanbay M, Solak Y, Unal HU, et al.Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619-1625.
[23] Li Y, Li S, Ma Y, et al.Relationship between non-high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease. Coron Artery Dis. 2020;31(7):623-627.
[24] Joshi PH, de Lemos JA. Diagnosis and Management of Stable Angina: A Review. JAMA. 2021;325(17):1765-1778.
[25] Gillen C, Goyal A. Stable Angina.In: StatPearls. Treasure Island (FL): StatPearls Publishing; December 19, 2022.
[26] Akboga MK, Balci KG, Maden O, et al.Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375-383.
[27] Kundi H, Kiziltunc E, Cetin M, et al.Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Zusammenhang des Monozyten-/HDL-C-Quotienten mit dem SYNTAX-Score bei Patienten mit stabiler koronarer Herzkrankheit. Herz. 2016;41(6):523-529.
[28] Canpolat U, Çetin EH, Cetin Set al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin. Appl. Thromb. Hemost. pii: 1076029615594002 (2015) (Epub ahead of print).
[29] Xu W, Guan H, Gao D, et al.Sex-specific association of monocyte count to high-density lipoprotein ratio with SYNTAX score in patients with suspected stable coronary artery disease. Medicine (Baltimore). 2019;98(41):e17536.
[30] 聂文文. STEMI合并T2DM患者AIP、MHR水平及其与冠脉病变严重程度、短期预后的相关性[D].南华大学,2022.
[31] Li C, Fan H, Liu Y, et al.The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann Transl Med. 2021;9(21):1627.
[32] Cetin EHO, Cetin MS, Canpolat U, et al.Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med 2015;9:967-977.
[33] Karataş MB, Çanga Y, Özcan KS, et al.Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am [J] Emerg Med. 2016;34(2):240-244.
[34] 黄金凯,余志敏,胡建华等.MHR联合NLR检测与急性ST段抬高型心肌梗死患者PCI术后短期不良预后的相关性[J].武汉大学学报(医学版),2023,44(1):87-91.
[35] 张增磊,郑颖颖,唐俊楠,等.术前单核细胞与高密度脂蛋白胆固醇比值对冠心病PCI术后患者预后的预测[J].郑州大学学报(医学版),2020,55(3):305-308.
[36] Villanueva DLE, Tiongson MD, Ramos JD, et al.Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis.2020;19(1):55. Published 2020 Mar 26.
[37] Wang P, Guo X, Zhou Y, et al.Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol (Lausanne). 2022;13:944991.
[38] Zhang Y, Li S, Guo YL, et al.Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48(5):305-312.
[39] 张丽秀,梁红萍.中性粒细胞与淋巴细胞比值、单核细胞与高密度脂蛋白胆固醇比值诊断急性冠脉综合征的临床价值[J].护理研究,2021,35(24):4372-4375.
[40] Wang HY, Shi WR, Yi X, et al.Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort. Lipids Health Dis.2019;18(1):127. Published 2019 May 30.
[41] 闫慧. MHR与阻塞性睡眠呼吸暂停低通气综合征患者心律失常的相关性研究[D].新疆医科大学,2023.
[42] 王一波,栾天竹.单核细胞与高密度脂蛋白比值在心血管疾病中的研究进展[J].临床与病理杂志,2022,42(1):226-231.
[43] 余嘉清. 单核细胞计数高密度脂蛋白胆固醇比值与扩张型心肌病慢性心力衰竭的相关性[D].新疆医科大学,2023.
[44] 晏心. MHR对于室性早搏患者左心室肥厚的筛检价值[D].南方医科大学,2024.
[45] 陈安琪,蒋鹏,吴云.MHR在评估常见心血管疾病中的研究进展[J].内蒙古医学杂志,2022,54(6):710-712,717. |
